Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

NCT04341181 is registered in ClinicalTrials.gov with Ulrik Lassen as lead sponsor.

NCT NCT04341181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
Lead sponsor
Ulrik Lassen
Phase
Phase 2
Overall status
Recruiting
Start date
August 24, 2020
Completion date
April 30, 2030
Enrollment
300 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, neoplasia, neoplasms, tumors